cryoablation
Showing 1 - 24 of 24
Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)
Not yet recruiting
- Desmoid Tumor
- Nirogacestat
- Cryoablation
-
Palo Alto, CaliforniaStanford University
Jul 7, 2023
Solid Tumor, Adult Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)
Recruiting
- Solid Tumor, Adult
- Tislelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 13, 2023
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023
Hepatocellular Carcinoma Trial (Cryoablation, Tislelizumab, Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma
- Cryoablation
- +2 more
- (no location specified)
May 31, 2023
Gastric Cancer Metastatic to Liver Trial in Shanghai (Cryoablation, Tislelizumab, Lenvatinib)
Not yet recruiting
- Gastric Cancer Metastatic to Liver
- Cryoablation
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 6, 2023
Advanced Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cryoablation, Sintilimab, Lenvatinib)
Recruiting
- Advanced Intrahepatic Cholangiocarcinoma
- Cryoablation
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 28, 2023
Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)
Not yet recruiting
- Metastatic Melanoma
- Skin Cancer
- Ipilimumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Mar 9, 2023
Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)
Recruiting
- Advanced Biliary Tract Cancer
- Sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 22, 2023
Melanoma Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)
Recruiting
- Melanoma
- Tislelizumab
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 8, 2022
Liver Metastasis Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)
Recruiting
- Liver Metastasis
- Sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 8, 2022
Breast Cancer Trial in New York (Cryoablation, Ipilimumab, Nivolumab)
Active, not recruiting
- Breast Cancer
- Cryoablation
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 1, 2022
Desmoid Tumor Trial in France (Cryoablation, Chemotherapy drug)
Not yet recruiting
- Desmoid Tumor
- Cryoablation
- Chemotherapy drug
-
Bordeaux, France
- +12 more
Oct 6, 2023
Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)
Recruiting
- Lung Adenocarcinoma
- Cryotherapy Effect
- Cryoablation
- +3 more
-
Bordeaux, Gironde, FranceInstitut Bergonié
Oct 29, 2021
Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Boston (Pembrolizumab, Cryoablation)
Recruiting
- Metastatic Urothelial Carcinoma
- Bladder Cancer
- Pembrolizumab
- Cryoablation
-
Boston, Massachusetts
- +1 more
Oct 27, 2021
Intrahepatic Cholangiocarcinoma Trial in Shanghai (cryoablation, Sintilimab, lenvatinib)
Recruiting
- Intrahepatic Cholangiocarcinoma
- cryoablation
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 23, 2021
Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial
Active, not recruiting
- Biliary Tract Neoplasms
- +4 more
- Durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 1, 2022
Soft Tissue Sarcoma Trial in Stanford (Ipilimumab, Cryoablation, Nivolumab)
Active, not recruiting
- Soft Tissue Sarcoma
- Ipilimumab
- +2 more
-
Stanford, CaliforniaStanford Medical Center
Feb 2, 2022
Renal Cell Carcinoma, Metastatic Kidney Cancer Trial in Orange (Pembrolizumab Injection [Keytruda], Cryoablation, Nephrectomy)
Withdrawn
- Renal Cell Carcinoma
- Metastatic Kidney Cancer
- Pembrolizumab Injection [Keytruda]
- +2 more
-
Orange, CaliforniaUC Irvine Health Department of Urology
Apr 1, 2021
Atrial Fibrillation, Atrial Fibrillation New Onset Trial in United States (Cryoablation, Antiarrhythmic drug)
Completed
- Atrial Fibrillation
- Atrial Fibrillation New Onset
- Cryoablation
- Antiarrhythmic drug
-
Birmingham, Alabama
- +23 more
Jul 20, 2021
Heptocellular Cancer, Biliary Tract Tumors, Liver Cancer Trial run by the NCI (Tremelimumab, RFA, TACE)
Completed
- Heptocellular Cancer
- +4 more
- Tremelimumab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 21, 2019
Cancer Trial in Baltimore (cyclophosphamide, Cryoablation)
Terminated
- Cancer
- cyclophosphamide
- Cryoablation
-
Baltimore, MarylandBrady Urological Institute at Johns Hopkins Hospital
Jan 16, 2019
Intermetatarsal Neuroma Trial in New York (Cryoablation, Lidocaine, Saline)
Completed
- Intermetatarsal Neuroma
- Cryoablation
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 3, 2018
Urinary Bladder Tumors Trial (Cryoablation, Epirubicin)
Unknown status
- Urinary Bladder Neoplasms
- Cryoablation
- Epirubicin
- (no location specified)
Oct 17, 2017
Stage IV Prostate Cancer Trial in Tianjin (cryoablation, Bicalutamide, luteinizing-hormone releasing-hormone (LHRH) agonist)
Unknown status
- Stage IV Prostate Cancer
- cryoablation
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jun 9, 2017